Drug intelligence / Profile preview

Arotrix-C

Development stage
Unknown
Lead developer
Aristopharma
Modality
Small Molecules
Administration
Topical
01

Overview

Arotrix-C is a topical combination antiparasitic cream developed and marketed by Aristopharma Ltd. in Bangladesh. It contains two active small-molecule agents: permethrin and crotamiton. Permethrin is a synthetic pyrethroid that functions as a neurotoxin to ectoparasites by binding to and disrupting the function of voltage-gated sodium channels in nerve cell membranes, leading to delayed repolarization and paralysis of the parasites. Crotamiton complements this action with its own scabicidal properties and provides symptomatic relief through its antipruritic (anti-itch) effect. The product is indicated for the treatment of skin infestations such as scabies (caused by *Sarcoptes scabiei*) and lice, as well as the management of associated pruritus.

Brand names
Arotrix-C
Other names
Permethrin + Crotamiton
02

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on Arotrix-C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arotrix-C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call